menu search

lonza: the day has come, and we lower our expectation

Here at the Lab, post Capital Market Day, we are in a show-me-story scenario. Moderna contract termination is a positive short-term catalyst; however,...

October 18, 2023, 4:43 am

lonza group: downside scenario already priced in

lonza's CEO departure raises questions about business continuity, but we believe the stock price alread...

October 5, 2023, 4:55 am

Moderna to cut mrna drug substance production at lonza facility

Moderna said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at lonza...

September 19, 2023, 10:56 am

Lon­za cites biotech fund­ing slow­down as it low­ers sales out­look for the year

Contract manufacturer lonza tempered its sales outlook for the rest of the year due in part to lower-th...

July 21, 2023, 3:14 pm

lonza delivers 5.6% cer sales growth, with underlying growth at around 10% cer and 30% core ebitda margin

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcem...

July 21, 2023, 5:29 am

lonza: our thoughts pre capital market day, buy confirmed

Despite a challenging economic environment, lonza announced an increase in CAPEX, positioning itself to...

June 30, 2023, 3:41 am

lonza group ag (lzagy) q1 2023 earnings call transcript

lonza Group AG (OTCPK:LZAGY) Q1 2023 Earnings Conference Call May 9, 2023 9:00 AM ET Company Participan...

May 10, 2023, 3:30 pm

Global tertiary amines market size forecasted to surpass $7.5 billion growth by 2030, exhibit a cagr of 6.12%

Global Tertiary Amines Market size & share revenue was valued at around USD 4.65 billion in 2022 and is estimated to grow about USD 7.5 billion by 203...

May 1, 2023, 7:11 am

lonza launches share buyback program of up to chf 2 billion

lonza Launches Share Buyback Program of up to CHF 2 Billion 31.03.2023 / 07:00 CET/CEST Basel, Switzerl...

March 31, 2023, 5:29 am

lonza group ag (lzagy) q4 2022 earnings call transcript

lonza Group AG (OTCPK:LZAGY) Q4 2022 Earnings Conference Call January 25, 2023 8:00 AM ET Company Parti...

January 25, 2023, 12:36 pm

lonza fy22 profit up, lifts dividend; sees higher fy23 sales, weak margin; plans chf 2 bln buyback

lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare and life-science industries, re...

January 25, 2023, 7:14 am

lonza delivers strong 2022 performance with 15.1% cer sales growth and 32.1% core ebitda margin

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcem...

January 25, 2023, 6:29 am

Context therapeutics announces manufacturing agreement with lonza for bispecific antibody targeting claudin 6 positive cancers

Context Therapeutics (NASDAQ:CNTX) Inc said it will be collaborating with lonza, a global development a...

January 9, 2023, 9:03 am

lonza group ag (lzagy) ceo pierre-alain ruffieux on q2 2022 results - earnings call transcript

lonza Group AG (OTCPK:LZAGY) Q2 2022 Earnings Conference Call July 22, 2022 8:00 AM ET Company Particip...

July 22, 2022, 7:59 pm

lonza: one stop shop for global drug manufacturing, at a price

lonza is the largest pure-play CDMO in the world. While pharmaceuticals and biotechs need to spend on r...

June 16, 2022, 1:54 pm


Search within

Pages Search Results: